Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT02784002
Eligibility Criteria:
Inclusion Criteria:
* Informed Consent
* Clinical diagnosis of CDI plus laboratory diagnostic test
* No more than 30 hours antimicrobial treatment for current CDI episode
* Female subjects of childbearing potential must use adequate contraception
Exclusion Criteria:
* Life-threatening or fulminant CDI
* Subjects with 2 or more episodes of CDI in the previous year
* Females who are pregnant or breastfeeding
* History of inflammatory bowel disease
* Co-administration of potent P-glycoprotein inhibitors
* Participation in other Clinical research studies within one month of screening
* Subjects that the Investigator feels are inappropriate for the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02784002
Study Brief:
Protocol Section:
NCT02784002